Alaunos Therapeutics, Inc.·4

Jan 15, 4:15 PM ET

Postma Robert W 4

4 · Alaunos Therapeutics, Inc. · Filed Jan 15, 2026

Insider Transaction Report

Form 4
Period: 2026-01-12
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-12$2.89/sh+5,622$16,24843,872 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    24
  • Common Stock

    [F2]
    (indirect: By WaterMill Asset Management Corp.)
    62,416
Footnotes (2)
  • [F1]Represents shares of common stock issued in lieu of board fees.
  • [F2]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
Signature
/s/ Postma, Robert W|2026-01-15

Documents

1 file
  • 4
    ownership.xmlPrimary

    4